Helicobacter pylori and atherosclerosis: can current data be useful for clinical practice?
Pellicano
R
R
Fagoonee
S
S
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000453:epidemiology / Q000517:prevention & control*; D003223:Congo / Q000453:epidemiology; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000453:epidemiology*; D016480:Helicobacter pylori; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000517:prevention & control*; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors
D000900:Anti-Bacterial Agents